Bottle of lies (Record no. 41002)

000 -LEADER
fixed length control field 02679nam a2200193 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200105020006.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190729b xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780062338785
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Terms of availability 006233879X
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Eban, Katherine
245 10 - TITLE STATEMENT
Title Bottle of lies
Remainder of title the inside story of the generic drug boom
Statement of responsibility, etc. Katherine Eban.
250 ## - EDITION STATEMENT
Edition statement First edition.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. New York, NY
Name of publisher, distributor, etc. Ecco, an imprint of HarperCollins Publishers
Date of publication, distribution, etc. [2019]
300 ## - PHYSICAL DESCRIPTION
Extent xxiv, 482 pages ;
Dimensions 24 cm.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Part I: Shifting ground. The man who saw further ; The gold rush ; A slum for the rich ; The language of quality ; Red flags -- Part II: India rises. Freedom fighters ; One dollar a day ; A clever way of doing things ; The assignment -- Part III: A cat-and-mouse business. The global cover-up ; Map of the world ; The pharaoh of pharma -- Part IV: Making a case. Out of the shadows ; "Do not give to FDA" ; "How big is the problem?" ; Diamond and ruby ; "You just don't get it" -- Part V: Detectives in the dark. Congress wakes up ; Solving for X ; A test of endurance ; A deep, dark well ; The $600 million jacket -- Part VI: The watershed. The light switch ; We are the champions ; Crashing files ; The ultimate testing laboratory -- Part VII: Reckonings. Flies too numerous to count ; Standing.
520 ## - SUMMARY, ETC.
Summary, etc. "Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban's Bottle of Lies exposes the deceit behind generic-drug manufacturing--and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?" -- Dust jacket.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books
Koha issues (borrowed), all copies 2
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Total Checkouts Full call number Barcode Checked out Date last seen Date last checked out Bill Date Koha item type
          WHO HQ WHO HQ BORROWABLE-COLL-STACKS 2019-07-29 1 QV 33.1 2019EB 00060020 2020-02-01 2020-01-04 2020-01-04 2019-07-29 Books